Connexin26 Modulates the Radiosensitivity of Cutaneous Squamous Cell Carcinoma by Regulating the Activation of the MAPK/NF-κB Signaling Pathway. This evidence concerns the gene NFKB1 and cutaneous squamous cell carcinoma.